Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewsIndia

COVID-19: Centre discontinues remdesivir allocation to states, says supply is more than demand

The Ministry of Chemicals and Fertilizers said that the production of remdesivir had been ramped up ten times from 33,000 vials/day on April 11, 2021, to 3,50,000 vials/day on May 29.

May 29, 2021 / 02:52 PM IST
Remdesivir is being widely used in treating COVID-19 patients and its demand has skyrocketed following a surge in coronavirus cases in India.(Representative image)

Remdesivir is being widely used in treating COVID-19 patients and its demand has skyrocketed following a surge in coronavirus cases in India.(Representative image)

The Centre, on May 29, announced that it will discontinue central allocation of remdesivir to states. Minister of State for Chemicals and Fertilizers Mansukh Mandaviya has directed the National Pharmaceuticals Pricing Agency and CDSCO to continuously monitor the availability of Remdesivir in the country.

Taking to Twitter, Mandaviya said, "Now the country has enough remdesivir as the supply is much more than the demand. So we have decided to discontinue the Central Allocation of remdesivir to states."


Track this LIVE blog for latest news on coronavirus pandemic